Susquehanna International Group
PDSB icon

Susquehanna International Group’s PDS Biotechnology PDSB Stock Holding History

Susquehanna International Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,800
Closed -$141K – 12957
2024
Q3 		$141K Buy
36,800
+20,100
+120% +$67.1K ﹤0.01% 10801
2024
Q2 		$48.9K Sell
16,700
-131,100
-89% -$419K ﹤0.01% 11422
2024
Q1 		$585K Sell
147,800
-38,600
-21% -$199K ﹤0.01% 8129
2023
Q4 		$926K Buy
186,400
+27,400
+17% +$136K ﹤0.01% 7165
2023
Q3 		$803K Buy
159,000
+24,600
+18% +$135K ﹤0.01% 7140
2023
Q2 		$676K Buy
134,400
+83,900
+166% +$549K ﹤0.01% 7601
2023
Q1 		$311K Sell
50,500
-70,300
-58% -$575K ﹤0.01% 9651
2022
Q4 		$1.59M Buy
120,800
+58,100
+93% +$410K ﹤0.01% 5146
2022
Q3 		$186K Sell
62,700
-59,000
-48% -$250K ﹤0.01% 10947
2022
Q2 		$444K Buy
121,700
+63,900
+111% +$304K ﹤0.01% 8570
2022
Q1 		$358K Buy
57,800
+3,600
+7% +$22.4K ﹤0.01% 9833
2021
Q4 		$439K Sell
54,200
-66,800
-55% -$719K ﹤0.01% 9526
2021
Q3 		$1.8M Sell
121,000
-83,700
-41% -$1.04M ﹤0.01% 6066
2021
Q2 		$2.57M Buy
+204,700
New +$1.6M ﹤0.01% 5362

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's PDSB Position: Q1 2026 in Review

Susquehanna International Group reduced its PDS Biotechnology (PDSB) stake by 43% in Q1 2026, selling an estimated $12.4K and leaving 22,052 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12910.

Susquehanna International Group first reported a position in PDSB in Q4 2015 and has held it in 25 quarters since. The position peaked at $5M in Q3 2021. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Susquehanna International Group held 22,052 shares of PDS Biotechnology worth $13.3K as of Q1 2026.
  • Susquehanna International Group sold 16,514 PDS Biotechnology shares in Q1 2026, an estimated $12.4K.
  • PDS Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12910 holding.
  • Susquehanna International Group first reported a position in PDS Biotechnology in Q4 2015 and has held it in 25 quarters since.
  • Susquehanna International Group's PDS Biotechnology position peaked at $5M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.